Related Experiment Video
Updated: Jul 7, 2025

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
Published on: January 7, 2019
Oncolytic Viruses in the Era of Omics, Computational Technologies, and Modeling: Thesis, Antithesis, and Synthesis
Laura Menotti1, Andrea Vannini1
1Department of Pharmacy and Biotechnology, University of Bologna, 40126 Bologna, Italy.
Abstract:
Oncolytic viruses (OVs) are the frontier therapy for refractory cancers, especially in integration with immunomodulation strategies. In cancer immunovirotherapy, the many available "omics" and systems biology technologies generate at a fast pace a challenging huge amount of data, where apparently clashing information mirrors the complexity of individual clinical situations and OV used. In this review, we present and discuss how currently big data analysis, on one hand and, on the other, simulation, modeling, and computational technologies, provide invaluable support to interpret and integrate "omic" information and drive novel synthetic biology and personalized OV engineering approaches for effective immunovirotherapy. Altogether, these tools, possibly aided in the future by artificial intelligence as well, will allow for the blending of the information into OV recombinants able to achieve tumor clearance in a patient-tailored way. Various endeavors to the envisioned "synthesis" of turning OVs into personalized theranostic agents are presented.
Insights
Oncolytic viruses (OVs) offer advanced cancer therapy. Big data analysis and computational modeling are key to personalizing OV engineering for effective cancer immunovirotherapy.
Area of Science:
- Oncology
- Virology
- Computational Biology
- Systems Biology
Background:
- Oncolytic viruses (OVs) represent a promising frontier therapy for refractory cancers.
- Integrating OVs with immunomodulation strategies enhances their therapeutic potential.
- Cancer immunovirotherapy generates vast amounts of complex 'omic' data.
Purpose of the Study:
- To review how big data analysis and computational technologies aid in interpreting 'omic' data for cancer immunovirotherapy.
- To discuss the role of simulation, modeling, and synthetic biology in engineering personalized OVs.
- To explore the development of OVs as patient-tailored theranostic agents.
Main Methods:
- Review of current literature on big data analysis in cancer immunovirotherapy.
- Discussion of simulation and modeling approaches for OV design.
- Exploration of synthetic biology and personalized OV engineering strategies.
Main Results:
- Big data analysis and computational tools are crucial for integrating complex 'omic' information.
- These technologies facilitate the development of novel synthetic biology and personalized OV engineering approaches.
- The integration of data and computational methods enables the creation of patient-tailored OV recombinants.
Conclusions:
- Computational technologies and big data analysis are indispensable for advancing cancer immunovirotherapy.
- These tools support the engineering of personalized oncolytic viruses for effective tumor clearance.
- Future advancements may involve artificial intelligence to further personalize OV theranostics.
Related Concept Videos
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Genomics
Synthetic Biology
Golden rice
Golden rice is a genetically modified...
Viral Recombination
Viral Mutations
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...

